Search Site

Trends banner

Sinovac

Pfizer poised to buy Metsera

The pharma giant improved its offer to $10bn.

Ozempic maker lowers outlook

The company posted tepid Q3 results.

Kimberly-Clark to buy Kenvue

The deal is valued at $48.7 billion.

BYD Q3 profit down 33%

This was a 33% year-on-year decrease.

Alphabet posts first $100 bn quarter

The growth was powered by cloud division buoyed by AI
  • Algeria begins Sinovac Covid-19 vaccine production

    Prime Minister Aimene Benabderrahmane, who attended the launch of the production process at a factory in the eastern city of Constantine, called it a "big achievement". Production could be doubled in the North African nation if needed, officials said.
  • China approves first mixed-vaccine trial as Delta spread

    The trial will test the efficacy of combining an "inactivated" vaccine made by China's Sinovac with a DNA-based one developed by US pharmaceutical company Inovio
  • Algeria to manufacture Chinese Sinovac vaccine

    Even as Sinovac will become the second Covid-19 vaccine to be manufactured locally in the country, only 10 percent of the 44 million population has been inoculated in nearly six months of the vaccination drive.
  • Chinese jab added hurdle for some African visitors to EU

      Travelers to Europe must be inoculated with the AstraZeneca, Johnson & Johnson, Pfizer/BioNTech and Moderna vaccines The Chinese vaccines Sinovac and Sinopharm have been the most widely used on the African continent Europe is gradually re-opening to vaccinated travelers as coronavirus restrictions ease, but in some African nations such...